| BCBS Highmark Penn Medicare Advantage | Pharmacogenomics Testing | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | Billing and Coding: Molecular Pathology and Genetic Testing | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | Immune Globulin | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | Belantamab mafodotin (Blenrep) | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | Ustekinumab (Stelara) and Ustekinumab Biosimilars | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | Monoclonal Antibodies for the Treatment of Eosinophilic Conditions | 2026-07-01 |
| BCBS Highmark Penn Medicare Advantage | Treatment of Spinal Muscular Atrophy | 2026-07-01 |
| BCBS Highmark NY and West NY | Pharmacogenetic/Pharmacogenomic Testing | 2026-07-01 |
| BCBS Highmark NY and West NY | Genetic Testing for Mitochondrial Disorders | 2026-07-01 |
| BCBS Highmark NY and West NY | Prostate Disease: Diagnosis, Staging, and Treatment | 2026-07-01 |